Trifecta Capital Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 245 shares of XBI stock, worth $22,023. This represents 0.01% of its overall portfolio holdings.
Number of Shares
245
Previous 245
-0.0%
Holding current value
$22,023
Previous $22.7 Million
6.57%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding XBI
# of Institutions
927Shares Held
101MCall Options Held
28.4MPut Options Held
33.4M-
Goldman Sachs Group Inc New York, NY12.7MShares$1.15 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY12.3MShares$1.1 Billion0.1% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A69.23MShares$830 Million2.24% of portfolio
-
Morgan Stanley New York, NY8.02MShares$721 Million0.06% of portfolio
-
Citigroup Inc7.75MShares$697 Million0.45% of portfolio